These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22535374)

  • 21. Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA.
    Fregien NL; White LA; Bunge MB; Wood PM
    Glia; 2005 Jan; 49(1):24-35. PubMed ID: 15390106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-targeting therapy against HER3/MET in human colorectal cancers.
    Yamasaki A; Miyake R; Hara Y; Okuno H; Imaida T; Okita K; Okazaki S; Akiyama Y; Hirotani K; Endo Y; Masuko K; Masuko T; Tomioka Y
    Cancer Med; 2023 Apr; 12(8):9684-9696. PubMed ID: 36751113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.
    Carrión-Salip D; Panosa C; Menendez JA; Puig T; Oliveras G; Pandiella A; De Llorens R; Massaguer A
    Int J Oncol; 2012 Sep; 41(3):1128-38. PubMed ID: 22684500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epigenetic role for PRL-3 as a regulator of H3K9 methylation in colorectal cancer.
    Liu Y; Zheng P; Liu Y; Ji T; Liu X; Yao S; Cheng X; Li Y; Chen L; Xiao Z; Zhou J; Li J
    Gut; 2013 Apr; 62(4):571-81. PubMed ID: 22345654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
    Momeny M; Saunus JM; Marturana F; McCart Reed AE; Black D; Sala G; Iacobelli S; Holland JD; Yu D; Da Silva L; Simpson PT; Khanna KK; Chenevix-Trench G; Lakhani SR
    Oncotarget; 2015 Feb; 6(6):3932-46. PubMed ID: 25668816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
    Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
    Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of inhibition effect of herceptin on interaction between heregulin and erbB receptors HER3/HER2 by single-molecule force spectroscopy.
    Shi X; Xu L; Yu J; Fang X
    Exp Cell Res; 2009 Oct; 315(16):2847-55. PubMed ID: 19497323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
    Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
    Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1-integrin-dependent mechanism.
    Widder M; Lützkendorf J; Caysa H; Unverzagt S; Wickenhauser C; Benndorf RA; Schmoll HJ; Müller-Tidow C; Müller T; Müller LP
    Int J Cancer; 2016 Feb; 138(4):964-75. PubMed ID: 26356035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation.
    Stove C; Stove V; Derycke L; Van Marck V; Mareel M; Bracke M
    J Invest Dermatol; 2003 Oct; 121(4):802-12. PubMed ID: 14632199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW; Stonecypher MS; Carroll SL
    Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition.
    Jia X; Wang H; Li Z; Yan J; Guo Y; Zhao W; Gao L; Wang B; Jia Y
    Mol Med Rep; 2020 Apr; 21(4):1779-1788. PubMed ID: 32319604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer.
    Yonezawa M; Wada K; Tatsuguchi A; Akamatsu T; Gudis K; Seo T; Mitsui K; Nagata K; Tanaka S; Fujimori S; Sakamoto C
    Digestion; 2009; 80(4):215-25. PubMed ID: 19797898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
    Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
    J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells.
    Hirata A; Hosoi F; Miyagawa M; Ueda S; Naito S; Fujii T; Kuwano M; Ono M
    Cancer Res; 2005 May; 65(10):4253-60. PubMed ID: 15899817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.